Diabetes Mellitus Clinical Trials in Paris
7 recruitingParis, France
Showing 1–7 of 7 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Eli Lilly and Company300 enrolled129 locationsNCT07222332
Recruiting
Phase 3
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Diabetes Mellitus, Type 1
Eli Lilly and Company150 enrolled108 locationsNCT07222137
Recruiting
Phase 2
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
Type 1 Diabetes Mellitus
Sanofi192 enrolled80 locationsNCT06111586
Recruiting
French Prospective Multicentric Study in Real World
Diabetes MellitusDiabetesType 1 Diabetes
Insulet Corporation304 enrolled24 locationsNCT07039942
Recruiting
Not Applicable
The Effect of Hedia Diabetes Assistant on TiMe-in-range in People With Type 1 Diabetes and Sub-Optimal Glycemic Control in France - A Randomised Controlled Trial.
Type 1 Diabetes Mellitus (T1DM)
Hedia ApS154 enrolled6 locationsNCT06819306
Recruiting
French National Cohort of People With Type 1 Diabetes
Cardiovascular DiseasesPatient ParticipationDiabetes Mellitus, Type 1+1 more
Fondation Francophone pour la Recherche sur le Diabete15,000 enrolled1 locationNCT04657783